PharmD, HCP, hospital, Faculty, Authorship and Pharma... and gamer. 360° overview of Healthcare! Views&comments that I'm sharing are my own.
France
Joined August 2019
- Tweets93
- Following59
- Followers32
- Likes101
Janus Nicolas retweeted
eGFR slope as predictor of mortality in heart failure patients #HeartFailure vs. #CKD Take a look in #ESCHeartFailure 👉 bit.ly/3OVbpQK
@EJHFEiC @JanBiegus @Ppponikowski #HFA_ESC @hvanspall @ShelleyZieroth @FudimMarat @gcfmd @AlexMebazaa @MarcoMetra @GianluSava
Janus Nicolas retweeted
Kim learned to manage her atopic dermatitis (AD) and now feels more confident about living life on her terms.
Watch Kim’s full video here: brnw.ch/21wEG6U
#ADDaysAroundTheWorld
Janus Nicolas retweeted
Our thrombosis team is excited to attend #Vascular2023. We look forward to the knowledge, insights, and the latest innovations shared, that will help push the boundaries in thrombosis care and improve outcomes for patients worldwide.
#LEOPharma #Thromobosis #PatientsFirst
Janus Nicolas retweeted
Are you responsible for teaching the #coagulation cascade?
Check out this incredible new #RPTHIllustratedReview for great visuals & the newest insights from experimental and computational studies! bit.ly/3ECoOb7
Janus Nicolas retweeted
Our team is delighted to attend #ISTH2023! We look forward to experiencing the latest science in thrombosis and engaging with international thought leaders.
Visit us at booth #2213
Janus Nicolas retweeted
Dr. @DebSiegal presenting at #ASH21 Patients with cancer without a prior history of stroke are at higher risk of ischemic stroke (1.5 fold) and mortality (10 fold) at 1.5 years compared to cancer-free patients
@canvector @ThrombosisCan
Janus Nicolas retweeted
Looking forward to a terrific meeting!
VTE Dublin 2021 is ready to go. We are virtual again this year but remain FREE to all. October 7th and 8th 2021. Check out the programme below and register at VTEdublin.org
Janus Nicolas retweeted
Exceptionnellement, nous avons décidé de mettre cet article à disposition gratuitement, tant ces informations sont utiles pour comprendre l'épidémie buff.ly/3zyQNV4
Janus Nicolas retweeted
@CircRes Review Alert! Check out the latest review on #CardioOnc from @baik_alan & colleagues. Mechanisms of #Cardiovascular #Toxicities Associated with #Immunotherapies. Learn more at ow.ly/Gq5F30rGyyg
@CardioOncology
Janus Nicolas retweeted
Interested by #thrombosis prevention in patients with #cancer ?
Join us to the #10ICTHIC poster session at 11.00 AM !
@ICTHIC #icthic
Janus Nicolas retweeted
Let's #DiscussCLOTPlus Monday: "The increased risk of #bleeding due to drug-drug interactions in patients administered direct oral #anticoagulants."
#Clots #Research #Evidence #VTE #AF
bit.ly/2Tuqw6E
Janus Nicolas retweeted
#ClotChat: The patient voice is vital in our work to identify and treat #bloodclots - see the hundreds of stories we have on the #WorldThrombosisDay website at worldthrombosisday.org #WTDay20
Janus Nicolas retweeted
Symposium sur "Thrombose et cancer" ce jour à #SFMV2020.
Ravi d'intervenir avec I MAHE et B BLANCHET, sous la direction de @Echoraljpangio.
En espérant que la retransmission internet permettra tout de même les échanges.
Janus Nicolas retweeted
How many patients recover from acute kidney injury after pulmonary embolism?
E-POSTER Nr 3450
Janus Nicolas retweeted
Acute kidney injury occurs in 1 of 3 patients diagnosed with PE.
🤔 How many of them recover a normal renal function?
See the work leaded by @MartinMurgier and L Fouillet, from @ChuSaintEtienne @MedvascC @Univ_St_Etienne ⤵️
#ERSCongress #erscongress2020 #AKI
Consensus statement of the Spanish Society of Internal Medicine and the Spanish Society of Medical Oncology on secondary thromboprophylaxis in patients with cancer
pubmed.ncbi.nlm.nih.gov/3288…
Janus Nicolas retweeted
What are the essential aspects of the follow‐up after acute pulmonary embolism? Our visual summary published today online in @RPTH: onlinelibrary.wiley.com/doi/…. This was great fun! Thanks to @MaryCushmanMD for providing us the opportunity. @TromboseLeiden
